IP
InMed Pharmaceuticals Inc
🇺🇸XNAS.INMUnited StatesHealthcare
$1.30USDunchanged 0.00 (0%)OpenEnd of day3:30 PM
Price$1.300.00 (0%)
Profile
- Healthcare
- Drug Manufacturers - Specialty & Generic
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- CA4576377002
- CUSIP
- 457637502
Company
- Employees
- 13
- Headquarters
- Vancouver, United States
- Website
- https://www.inmedpharma.com
- CEO
- Mr. Eric A. Adams B.S. Chem., M.I.B.
Market
- Shares outstanding
- 5.5M
- Market cap
- $7.14M
Key dates
- Next earnings
- Sep 28, 2026
Highlights
- Market cap
- $7.14M
- EPS LTM
- -$2.87
- P/E LTM
- -0.54
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $2.72B+50,128.13%up year on year
- Net income
- -$12.56M-42.58%down year on year
- Gross margin
- 35.56%+0.52%up year on year
- Free cash flow
- -$7.04B-90,547.4%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.